Sotac Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln M/S

NSE: SOTAC Small Cap ISIN: INE0O2D01012

As on 31 January 2025 at 14:35 IST

₹-

+ 0.00

(0.00%)

Sell Buy

Over 1 Month

2.79%

Over 6 Months

-24.44%

Over 1 Year

-13.01%

Over 3 Years

Sotac Pharmaceuticals Ltd Summary

Close -

Open -

High -

Low -

Volume -

Net Turnover (in ₹ Cr) ₹ 0.012

52Wk High ₹ 202.80

52Wk Low ₹ 87.10

52Wk High / Low

87.10

202.80

Sotac Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 118.24

EPS (TTM) 4.67

Book Value (BV) 45.60

Div. Yield -

P/E (TTM) 23.67

Price/Book Value 2.35

Delivery % -

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 14.18

ROE 32.04

Debt-Equity 0.64

Net Profit Margin 7.76

Operating Profit Margin 14.64

Sotac Pharmaceuticals Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019
Total Revenue	104.32	77.83	48.95	28.83	-
Total Expenses	100.12	74.49	51.01	28.47	-
Profit Before Tax	3.96	3.93	-2.06	0.36	-
Profit After Tax	3.58	2.29	-2.37	0.09	-
Operating Profit after Depreciation	5.90	5.32	-1.03	0.68	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019
Fixed Assets	35.51	25.92	16.56	15.99	-
Total Non Current Assets	44.68	26.50	17.35	16.63	-
Total Current Assets	60.65	47.14	17.35	13.75	-
TOTAL ASSETS	105.33	73.64	34.70	30.38	-
Total Shareholder's Fund	45.26	19.46	2.49	3.06	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2021	FY 2020	FY 2019
Net Cash from Operating Activities	-16.12	8.14	-0.31	0.06	-
Net Cash used in Investing Activities	-19.68	-11.67	-3.23	-11.75	-
Net Cash used in Financing Activities	29.54	13.14	3.38	11.40	-

Particulars (in ₹ Cr.)	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Total Revenue	58.23	73.36	43.79	-	-
Total Expenses	52.26	68.67	42.30	-	-
Profit Before Tax	5.96	4.69	1.48	-	-
Profit After Tax	4.50	3.30	1.48	-	-
Operating Profit after Depreciation	6.83	5.24	2.10	-	-

Balance Sheet

Particulars (in ₹ Cr.)	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Fixed Assets	14.09	8.80	6.42	-	-
Total Non Current Assets	18.18	8.80	8.46	-	-
Total Current Assets	36.61	27.50	14.03	-	-
TOTAL ASSETS	54.78	36.30	22.49	-	-
Total Shareholder's Fund	20.99	7.10	4.81	-	-

Cash Flow

Particulars (in ₹ Cr.)	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Net Cash from Operating Activities	8.54	3.58	2.22	-	-
Net Cash used in Investing Activities	-10.93	-3.28	-1.07	-	-
Net Cash used in Financing Activities	11.97	-0.30	-1.17	-	-

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	-	25.25	26.45	25.74	26.67
Total Expenses	-	23.03	25.27	22.83	24.59
Profit Before Tax	-	1.30	0.30	1.47	0.68
Profit After Tax	0.42	1.35	1.51	0.88	0.21
Operating Profit after Depreciation	-	2.47	1.53	3.52	2.13

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	-	13.01	16.31	17.68	14.20
Total Expenses	-	10.91	14	14.75	11.52
Profit Before Tax	-	1.67	1.86	2.06	2.15
Profit After Tax	0.86	1.25	1.38	1.49	1.67
Operating Profit after Depreciation	-	2.53	2.84	3.20	2.97

Sotac Pharmaceuticals Ltd Technicals

Support and Resistance

No data available

Moving Average

20 SMA 109.76

50 SMA 122.11

100 SMA 134.35

200 SMA 129.51

Sotac Pharmaceuticals Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

Sotac Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Sotac Pharmaceuticals Ltd	₹107	₹118.24
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Sotac Pharmaceuticals Ltd News

Sotac Pharmaceuticals schedules board meeting

On 29 October 2024

26 Oct 2024, 10:22 am

Sotac Pharmaceuticals AGM scheduled

On 27 September 2024

30 Aug 2024, 04:55 pm

Sotac Pharmaceuticals to conduct board meeting

On 13 August 2024

09 Aug 2024, 04:36 pm

Sotac Pharmaceuticals to conduct board meeting

On 17 May 2024

10 May 2024, 12:07 pm

Sotac Pharmaceuticals to discuss results

On 5 February 2024

22 Jan 2024, 05:40 pm

Sotac Pharmaceuticals Ltd Stock Analysis

Annual revenue for Sotac Pharmaceuticals Ltd decreased by 100.00% to ₹0 crore in FY 2024 from ₹58.23 crore in FY 2023.
Annual Net Profit for Sotac Pharmaceuticals Ltd decreased by 100.00% to ₹0 crore in FY 2024 from ₹4.50 crore in FY 2023.
Promoter Shareholding in Sotac Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 72.85% in March 2024 to 72.85% in September 2024.
Sotac Pharmaceuticals Ltd delivered a 1-year return of -13.01% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Sotac Pharmaceuticals Ltd share price moved down by 100.00% from its previous close of INR ₹107. The latest Sotac Pharmaceuticals Ltd share price is INR ₹0.
Sotac Pharmaceuticals Ltd share price today has been at a low of 107 and a high of 107. Over the past 52 weeks, the Sotac Pharmaceuticals Ltd share price has seen a low of 87.10 and a high of 202.80.